About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

  

 

Investor Relations: Investor Packet Request

 
 

8/29/2014 - Daxor Corporation Announces Filing of Form N-CSR for June 30, 2014

  

6/19/2014 - Daxor to Explore Possible Partnership or Partial Sale of the Company

  

5/30/2014 - Heart Failure Study From the Mayo Clinic Utilizing Daxor’s BVA-100 Blood Volume Analyzer Published in Journal of the American College of Cardiology – Heart Failure

  
 

______________________

 
     
  Form N-CSR for Jun 30, 2014  
  Form N-Q for Mar 31, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  
 

Please fill in the following form to have your request e-mailed to DAXOR Corporation. One of our staff will contact you promptly.

Name:
Address 1:
Address 2:
City:
State:
ZIP/postal code
Country:
Telephone number:
E-mail address:
Message or
comments:

 

 

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

 


© 2014 DAXOR Corporation. All Rights Reserved.